Brain correlates of depression, post-traumatic distress, and inflammatory biomarkers in COVID-19 survivors: A multimodal magnetic resonance imaging study.
Anxiety
COVID-19
Depression
Diffusion-tensor imaging
Functional connectivity
Grey matter
Magnetic resonance imaging
PTSD
Resting state
SARS-COV-2
White matter
Journal
Brain, behavior, & immunity - health
ISSN: 2666-3546
Titre abrégé: Brain Behav Immun Health
Pays: United States
ID NLM: 101759062
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
26
10
2021
accepted:
31
10
2021
pubmed:
9
11
2021
medline:
9
11
2021
entrez:
8
11
2021
Statut:
ppublish
Résumé
Psychiatric sequelae substantially contribute to the post-acute burden of disease associated with COVID-19, persisting months after clearance of the virus. Brain imaging shows white matter (WM) hypodensities/hyperintensities, and the involvement of grey matter (GM) in prefrontal, anterior cingulate (ACC) and insular cortex after COVID, but little is known about brain correlates of persistent psychopathology. With a multimodal approach, we studied whole brain voxel-based morphometry, diffusion-tensor imaging, and resting-state connectivity, to correlate MRI measures with depression and post-traumatic distress (PTSD) in 42 COVID-19 survivors without brain lesions, at 90.59 ± 54.66 days after COVID. Systemic immune-inflammation index (SII) measured in the emergency department, which reflects the immune response and systemic inflammation based on peripheral lymphocyte, neutrophil, and platelet counts, predicted worse self-rated depression and PTSD, widespread lower diffusivity along the main axis of WM tracts, and abnormal functional connectivity (FC) among resting state networks. Self-rated depression and PTSD inversely correlated with GM volumes in ACC and insula, axial diffusivity, and associated with FC. We observed overlapping associations between severity of inflammation during acute COVID-19, brain structure and function, and severity of depression and post-traumatic distress in survivors, thus warranting interest for further study of brain correlates of the post-acute COVID-19 syndrome. Beyond COVID-19, these findings support the hypothesis that regional GM, WM microstructure, and FC could mediate the relationship between a medical illness and its psychopathological sequelae, and are in agreement with current perspectives on the brain structural and functional underpinnings of depressive psychopathology.
Identifiants
pubmed: 34746876
doi: 10.1016/j.bbih.2021.100387
pii: S2666-3546(21)00190-3
pmc: PMC8562046
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100387Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
None.
Références
Lancet Psychiatry. 2021 May;8(5):416-427
pubmed: 33836148
Depress Anxiety. 2016 Jul;33(7):592-605
pubmed: 26918313
Annu Rev Psychol. 2002;53:545-74
pubmed: 11752496
Neuroimage. 2002 Sep;17(1):479-89
pubmed: 12482100
J Affect Disord. 2012 Apr;138(1-2):9-18
pubmed: 21511342
Radiology. 2000 Sep;216(3):881-5
pubmed: 10966726
Arch Gen Psychiatry. 2002 Jul;59(7):597-604
pubmed: 12090812
Brain Res. 2012 Nov 12;1484:50-6
pubmed: 23010311
Neurosci Biobehav Rev. 2014 Jun;43:163-72
pubmed: 24769403
Brain Behav Immun Health. 2021 Oct;16:100290
pubmed: 34230916
Science. 2004 Oct 15;306(5695):443-7
pubmed: 15486290
Arch Gen Psychiatry. 1965 Jan;12:63-70
pubmed: 14221692
Neuroimage. 2012 Feb 15;59(4):3774-83
pubmed: 22119648
Nat Commun. 2018 Jun 8;9(1):2243
pubmed: 29884867
Neuroimage. 2009 Jan 1;44(1):83-98
pubmed: 18501637
Transl Psychiatry. 2017 Feb 14;7(2):e1031
pubmed: 28195568
Neuropsychopharmacology. 2013 Oct;38(11):2179-87
pubmed: 23657438
Mol Psychiatry. 2017 Oct;22(10):1455-1463
pubmed: 27217146
Neuroreport. 2000 Jun 5;11(8):1739-44
pubmed: 10852235
Cereb Cortex. 2019 Jan 1;29(1):202-214
pubmed: 29202177
Neuroimage. 2003 Nov;20(3):1714-22
pubmed: 14642481
J Neurosci. 2007 Feb 28;27(9):2349-56
pubmed: 17329432
Arch Gen Psychiatry. 2007 Feb;64(2):179-87
pubmed: 17283285
Curr Psychiatry Rep. 2006 Dec;8(6):458-63
pubmed: 17162825
J Psychiatr Res. 2021 Jan;132:207-214
pubmed: 33189355
Neuroimage. 2010 Oct 15;53(1):303-17
pubmed: 20600998
PLoS One. 2020 Oct 14;15(10):e0239570
pubmed: 33052920
Am J Psychiatry. 2003 Jan;160(1):64-75
pubmed: 12505803
Pain. 2017 Oct;158(10):1979-1991
pubmed: 28692006
Nat Rev Neurosci. 2003 Jun;4(6):469-80
pubmed: 12778119
Arch Ital Biol. 2009 Sep;147(3):83-93
pubmed: 20014654
J Affect Disord. 2016 Sep 15;202:1-9
pubmed: 27253210
Neuroimage Clin. 2016 May 09;12:1004-1012
pubmed: 27995066
Biophys J. 1994 Jan;66(1):259-67
pubmed: 8130344
Brain Behav Immun. 2021 May;94:138-147
pubmed: 33639239
Sci Rep. 2016 Sep 21;6:33748
pubmed: 27651030
Brain Behav Immun. 2020 Aug;88:39-43
pubmed: 32464158
Eur Neuropsychopharmacol. 2016 Dec;26(12):2000-2010
pubmed: 27756525
Neuropsychopharmacology. 2020 Nov;45(12):2058-2069
pubmed: 32740651
Eur Neuropsychopharmacol. 2021 Apr;45:89-107
pubmed: 33386229
Neuroimage. 2020 Nov 1;221:117177
pubmed: 32702484
Am J Psychiatry. 2020 May 1;177(5):381-390
pubmed: 32354265
Behav Res Ther. 2003 Dec;41(12):1489-96
pubmed: 14705607
J Affect Disord. 2011 Apr;130(1-2):220-5
pubmed: 21030090
Biol Psychiatry. 2004 Feb 1;55(3):201-7
pubmed: 14744459
Nat Rev Neurol. 2020 Nov;16(11):636-644
pubmed: 32839585
J Neuroimmune Pharmacol. 2021 Mar;16(1):1-3
pubmed: 33107012
Neuroimage. 2008 Apr 1;40(2):759-766
pubmed: 18221890
Lancet Psychiatry. 2021 Feb;8(2):130-140
pubmed: 33181098
Biol Psychiatry Cogn Neurosci Neuroimaging. 2021 Mar;6(3):352-359
pubmed: 33386283
Mol Psychiatry. 2016 Oct;21(10):1358-65
pubmed: 26552591
Neuroimage Clin. 2014 Mar 12;4:481-7
pubmed: 24818074
Cereb Cortex. 2018 Feb 1;28(2):726-737
pubmed: 29161362
Am J Psychiatry. 2018 Oct 1;175(10):989-998
pubmed: 30021460
Proc Natl Acad Sci U S A. 2019 Apr 30;116(18):9078-9083
pubmed: 30979801
Curr Opin Psychiatry. 2006 Jan;19(1):34-9
pubmed: 16612176
Nat Rev Immunol. 2016 Jan;16(1):22-34
pubmed: 26711676
Int J Psychiatry Clin Pract. 2021 Jun;25(2):109-114
pubmed: 32662692
Expert Rev Neurother. 2019 Feb;19(2):159-172
pubmed: 30599797
Brain Behav Immun. 2020 Oct;89:594-600
pubmed: 32738287
Neuroimage. 2004;23 Suppl 1:S208-19
pubmed: 15501092
Harv Rev Psychiatry. 2014 Nov-Dec;22(6):338-41
pubmed: 25377606
Neuroimage. 2012 Feb 1;59(3):2678-88
pubmed: 21914485
Mol Psychiatry. 2021 Dec;26(12):7475-7480
pubmed: 34285348
Psychiatry Res. 2015 Apr 30;232(1):1-33
pubmed: 25735885
J Neurophysiol. 2008 Dec;100(6):3328-42
pubmed: 18799601
Environ Res. 1999 May;80(4):348-54
pubmed: 10330308
J Affect Disord. 2020 Sep 1;274:1049-1056
pubmed: 32663931
Brain Behav Immun. 2019 Oct;81:410-421
pubmed: 31254622
Neuroimage. 2021 Sep;238:118242
pubmed: 34098066
Neuroimage. 2009 Mar;45(1 Suppl):S173-86
pubmed: 19059349
J Neurol. 2021 Dec;268(12):4436-4442
pubmed: 33973106
Front Psychiatry. 2020 Feb 26;11:71
pubmed: 32174850
Neuropsychopharmacology. 2019 Dec;44(13):2285-2293
pubmed: 31434102
Psychiatry Res. 2015 Aug 30;233(2):243-53
pubmed: 26195295
Acta Psychiatr Scand. 2010 Jan;121(1):33-40
pubmed: 19426163
Brain Behav Immun. 2020 Oct;89:543-554
pubmed: 32682993
Neuroimage Clin. 2018 May 16;19:581-598
pubmed: 29984166
Hum Brain Mapp. 2021 Apr 1;42(5):1268-1286
pubmed: 33274823
Front Psychol. 2017 Dec 12;8:2151
pubmed: 29312038
Brain. 2012 May;135(Pt 5):1498-507
pubmed: 22418737
Nat Med. 2021 Apr;27(4):601-615
pubmed: 33753937
J Affect Disord. 2020 Apr 1;266:655-670
pubmed: 32056942
Psychol Med. 2014 Oct;44(13):2833-43
pubmed: 25066703
Magn Reson Med. 2006 Feb;55(2):302-8
pubmed: 16408263
Eur Neuropsychopharmacol. 2020 May;34:28-38
pubmed: 32238313